MeSH term
Frequency | Condition_Probility | Alleles | 12 | 0.0 |
Chromosome Mapping | 7 | 0.0 |
Comparative Study | 9 | 0.0 |
Female | 29 | 0.0 |
*Genome, Human | 2 | 0.0 |
Genotype | 13 | 0.0 |
Humans | 57 | 0.0 |
Linkage (Genetics) | 10 | 0.0 |
Lod Score | 5 | 0.0 |
Male | 25 | 0.0 |
Pedigree | 6 | 0.0 |
Research Support, Non-U.S. Gov't | 30 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 25 | 0.0 |
Asian Continental Ancestry Group/genetics | 2 | 0.0 |
*Chromosome Mapping | 3 | 0.0 |
Chromosomes, Human, Pair 4/genetics | 2 | 2.0 |
Chromosomes, Human, Pair 6/genetics | 2 | 1.0 |
Cleft Lip/*genetics | 18 | 29.0 |
Cleft Palate/*genetics | 19 | 26.0 |
Genetic Markers/genetics | 2 | 0.0 |
Models, Genetic | 4 | 0.0 |
*Transcription Factors | 3 | 0.0 |
Transforming Growth Factor alpha/genetics | 4 | 15.0 |
Animals | 9 | 0.0 |
DNA-Binding Proteins/*genetics | 2 | 0.0 |
*Gene Expression Regulation, Neoplastic | 3 | 0.0 |
Membrane Proteins/genetics | 2 | 0.0 |
Mice | 5 | 0.0 |
Molecular Sequence Data | 6 | 0.0 |
Transcription Factors/*genetics | 3 | 0.0 |
Tumor Cells, Cultured | 4 | 0.0 |
Adolescent | 4 | 0.0 |
Adult | 9 | 0.0 |
Child | 5 | 0.0 |
Exons/genetics | 2 | 0.0 |
Haplotypes | 2 | 0.0 |
Homeodomain Proteins/*genetics | 3 | 0.0 |
Introns/genetics | 2 | 0.0 |
Middle Aged | 4 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Polymorphism, Single-Stranded Conformational | 2 | 0.0 |
Sequence Analysis, DNA | 3 | 0.0 |
Transforming Growth Factor alpha/*genetics | 20 | 43.0 |
Transforming Growth Factor alpha/metabolism | 2 | 2.0 |
Brazil | 2 | 0.0 |
Case-Control Studies | 10 | 0.0 |
Child, Preschool | 2 | 0.0 |
Gene Frequency | 7 | 0.0 |
Polymorphism, Restriction Fragment Length | 7 | 0.0 |
Base Sequence | 4 | 0.0 |
Cleft Lip/etiology/*genetics | 2 | 40.0 |
*Mutation | 2 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
Rats | 3 | 0.0 |
Epidermal Growth Factor/metabolism | 2 | 0.0 |
Infant, Newborn | 4 | 0.0 |
Pregnancy | 5 | 0.0 |
Risk Factors | 5 | 0.0 |
Smoking/*adverse effects | 4 | 1.0 |
European Continental Ancestry Group/genetics | 4 | 0.0 |
Genetic Markers | 5 | 0.0 |
Nuclear Family | 3 | 1.0 |
Transforming Growth Factor beta/*genetics | 2 | 2.0 |
Variation (Genetics) | 5 | 0.0 |
Cohort Studies | 2 | 0.0 |
Confidence Intervals | 2 | 0.0 |
DNA/genetics | 3 | 0.0 |
Heterozygote | 2 | 0.0 |
Interviews | 2 | 4.0 |
Odds Ratio | 3 | 0.0 |
Population Surveillance | 2 | 1.0 |
Linkage Disequilibrium | 3 | 0.0 |
Environment | 2 | 2.0 |
Infant | 3 | 0.0 |
Registries | 2 | 0.0 |
Cleft Lip/ethnology/*genetics | 2 | 100.0 |
Cleft Palate/ethnology/*genetics | 2 | 66.0 |
*Polymorphism, Genetic | 4 | 0.0 |
Family | 2 | 0.0 |
Prognosis | 3 | 0.0 |
Retrospective Studies | 2 | 0.0 |
Transforming Growth Factor alpha/*analysis | 2 | 3.0 |
Cell Division | 3 | 0.0 |
Gene Expression | 2 | 0.0 |
Transforming Growth Factor alpha/*biosynthesis | 2 | 9.0 |
Methylenetetrahydrofolate Reductase (NADPH2)/genetics | 2 | 4.0 |
Epithelium/chemistry/pathology | 2 | 5.0 |
Immunohistochemistry | 4 | 0.0 |
*Genes, Structural | 2 | 0.0 |
*Linkage (Genetics) | 2 | 0.0 |
*Polymorphism, Restriction Fragment Length | 3 | 0.0 |
English Abstract | 2 | 0.0 |
Cell Line | 2 | 0.0 |
Cells, Cultured | 2 | 0.0 |
Lipids/*metabolism | 2 | 0.0 |
Radioligand Assay | 2 | 0.0 |
Transforming Growth Factors | 4 | 4.0 |
Peptides/*genetics | 2 | 2.0 |
